Research programme: prostaglandin D2 receptor antagonists - Ligand Pharmaceuticals

Drug Profile

Research programme: prostaglandin D2 receptor antagonists - Ligand Pharmaceuticals

Alternative Names: CRTH2 Antagonist - Ligand Pharmaceuticals

Latest Information Update: 28 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ligand Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action Prostaglandin D2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Allergic rhinitis; Asthma; Chronic obstructive pulmonary disease

Most Recent Events

  • 22 Sep 2016 Research programme: prostaglandin D2 receptor antagonists - Ligand Pharmaceuticals licensed to Seelos Therapeutics
  • 01 Sep 2015 Prostaglandin D2 receptor antagonists are available for licensing as of 01 Sep 2015. http://www.ligand.com/
  • 01 Sep 2015 Preclinical trials in Allergic rhinitis, Asthma and Chronic obstructive pulmonary disease in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top